Responding to stressful events requires numerous adaptive actions involving integrated changes in the central nervous and neuroendocrine systems. Numerous studies have implicated dysregulation of stress-response mechanisms in the etiology of stress-induced psychopathophysiologies. The urocortin neuropeptides are members of the corticotropin-releasing factor family and are associated with the central stress response. In the current study, a tripleknockout (tKO) mouse model lacking all three urocortin genes was generated. Intriguingly, these urocortin tKO mice exhibit increased anxiety-like behaviors 24 h following stress exposure but not under unstressed conditions or immediately following exposure to acute stress. The inability of these mutants to recover properly from the exposure to an acute stress was associated with robust alterations in the expression profile of amygdalar genes and with dysregulated serotonergic function in stress-related neurocircuits. These findings position the urocortins as essential factors in the stress-recovery process and suggest the tKO mouse line as a useful stress-sensitive mouse model. amygdala | anxiety-like behaviors | serotonergic system | corticotropinreleasing factor | corticotropin-releasing factor receptor type 2 D ysregulation of stress-response mechanisms is proposed to underlie a variety of stress-related psychopathologies (1, 2). Corticotropin-releasing factor (CRF) plays a pivotal and wellestablished role in regulating the hypothalamic-pituitary-adrenal (HPA) axis under basal and stress conditions (3, 4) and, via its type 1 receptor (CRFR1), integrates the autonomic, metabolic and behavioral stress responses (5).The CRF peptide family includes also three urocortin (Ucn) peptides (Ucn1, Ucn2, and Ucn3) that bind and activate the CRF receptor type 2 (CRFR2) with high affinity (6-12). CRF has a relatively lower affinity for CRFR2 than for CRFR1; Ucn1 has equal affinities for both; and Ucns 2 and 3 appear to be selective for CRFR2 (6-9). These receptors are distributed differently throughout the brain: CRFR1 is widely expressed in various brain regions, whereas CRFR2 expression is more localized to selected stress-related brain nuclei, such as the amygdala, the bed nucleus of the stria terminalis (BNST), the lateral septum (LS), and the dorsal raphe nucleus (DRN) (13,14).Evidence from studies using competitive peptides or smallmolecule CRF/urocortin receptor antagonists suggested that the brain CRF/urocortin systems play diverse roles in mediating behavioral responses to stress (15). Based on the complementary behavioral phenotypes of CRFR1-and CRFR2-deficient (KO) mice, opposing roles were suggested for the two CRF receptors systems in modulating anxiety-like behaviors. CRFR1KO mice display decreased anxiety-like behaviors coupled with an impaired HPA axis stress response (16, 17), whereas CRFR2KO mice show increased anxiety-like behaviors and an accelerated HPA-axis response to stress (18,19). Thus, the CRF-CRFR1 system has been suggested as critical for initiating str...